JPH06501019A - ピリジルチオまたはピリジルオキシアルカン酸 - Google Patents

ピリジルチオまたはピリジルオキシアルカン酸

Info

Publication number
JPH06501019A
JPH06501019A JP3518250A JP51825091A JPH06501019A JP H06501019 A JPH06501019 A JP H06501019A JP 3518250 A JP3518250 A JP 3518250A JP 51825091 A JP51825091 A JP 51825091A JP H06501019 A JPH06501019 A JP H06501019A
Authority
JP
Japan
Prior art keywords
acid
pyridyl
compound
hydroxy
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3518250A
Other languages
English (en)
Japanese (ja)
Inventor
フレイジー，ジェイムズ・シンプソン
グリーソン，ジョン・ジェラルド
ホール，ラルフ・フロイド
キンジグ，チャールズ・マイケル
ユージンスカ，イレーネ・ニジョール
Original Assignee
スミスクライン・ビーチャム・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・コーポレイション filed Critical スミスクライン・ビーチャム・コーポレイション
Publication of JPH06501019A publication Critical patent/JPH06501019A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
JP3518250A 1990-09-13 1991-09-10 ピリジルチオまたはピリジルオキシアルカン酸 Pending JPH06501019A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58195890A 1990-09-13 1990-09-13
US581,958 1990-09-13

Publications (1)

Publication Number Publication Date
JPH06501019A true JPH06501019A (ja) 1994-01-27

Family

ID=24327273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3518250A Pending JPH06501019A (ja) 1990-09-13 1991-09-10 ピリジルチオまたはピリジルオキシアルカン酸

Country Status (10)

Country Link
EP (1) EP0548291A1 (fr)
JP (1) JPH06501019A (fr)
KR (1) KR930702304A (fr)
AU (1) AU8900391A (fr)
CA (1) CA2089728A1 (fr)
IE (1) IE913214A1 (fr)
MX (1) MX9101098A (fr)
PT (1) PT98974A (fr)
WO (1) WO1992005156A1 (fr)
ZA (1) ZA917261B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856322A (en) * 1990-10-12 1999-01-05 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
WO1994000433A1 (fr) * 1992-06-30 1994-01-06 Smithkline Beecham Corporation Procede de production de phenylthiomethylpyridinylalcenoates
ES2065234B1 (es) * 1992-10-27 1995-09-01 Smithkline Beecham Corp Compuestos para tratar enfermedades relacionadas con los leucotrienos.
AR029004A1 (es) * 1999-09-22 2003-06-04 Essential Therapeutics Inc Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana
FR2885616B1 (fr) * 2005-05-12 2007-06-22 Servier Lab Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885615B1 (fr) * 2005-05-12 2007-06-22 Servier Lab Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4

Also Published As

Publication number Publication date
EP0548291A1 (fr) 1993-06-30
MX9101098A (es) 1992-05-04
WO1992005156A1 (fr) 1992-04-02
PT98974A (pt) 1992-08-31
ZA917261B (en) 1992-09-30
AU8900391A (en) 1992-04-15
KR930702304A (ko) 1993-09-08
IE913214A1 (en) 1992-02-25
CA2089728A1 (fr) 1992-03-14

Similar Documents

Publication Publication Date Title
JPH06501019A (ja) ピリジルチオまたはピリジルオキシアルカン酸
EP0649412B1 (fr) Composes pharmaceutiques a base de pyridine
US5643914A (en) Pharmaceutical pyridine compounds
HU201521B (en) Process for producing benzenethio or benzylsulfonyl derivatives with leukotriene antagonist activity and pharmaceutical compositions comprising same
US4937253A (en) Ester prodrugs
EP0375348B1 (fr) Antagonistes de leukotriène
CN113166024A (zh) 芳族化合物及其医药用途
AU610528B2 (en) Leukotriene antagonists
US5569677A (en) Diphenyl-2-propenoates for treating diseases associated with leukotriene B4
JPH05507082A (ja) ５員環のアルカン酸であるロイコトリエン拮抗物質
JPS6259239A (ja) ロイコトリエン拮抗物質
JPH08253470A (ja) 新規チオフェン化合物、その製造方法及びそれらを含む医薬組成物
WO1995015752A1 (fr) Diphenyl-2-propenoates et leurs homologues, utiles dans le traitement des maladies associees a la leucotriene b4
US5189226A (en) Ortho-substituted benzaldehydes
JPH0324050A (ja) ロイコトリエン拮抗剤
EP0296731A1 (fr) Antagonistes de leukotriène
JPH08505148A (ja) ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物
CA1314654C (fr) Antagonistes des leucotrienes
JPH05506662A (ja) ３―ナフチル―３―カルボキシアルキルチオまたはオキシ置換アルカン酸ロイコトリエン拮抗剤
EP0733044A1 (fr) Composes
IE60494B1 (en) Leukotriene antagonists
CZ396891A3 (cs) Thiofenylalkanové kyseliny, způsob výroby a farmaceutické prostředky sjejich obsahem